Mirae Asset Global Investments’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$186K Buy
8,217
+596
+8% +$14.9K ﹤0.01% 1131
2026
Q1
$191K Sell
7,621
-2,898
-28% -$81.7K ﹤0.01% 1076
2025
Q4
$331K Buy
10,519
+869
+9% +$28.8K ﹤0.01% 1072
2025
Q3
$344K Buy
9,650
+224
+2% +$10.2K ﹤0.01% 1051
2025
Q2
$543K Buy
9,426
+647
+7% +$36.6K ﹤0.01% 930
2025
Q1
$527K Buy
8,779
+723
+9% +$49.4K ﹤0.01% 915
2024
Q4
$661K Sell
8,056
-164
-2% -$14K ﹤0.01% 903
2024
Q3
$654K Sell
8,220
-554
-6% -$39.4K ﹤0.01% 915
2024
Q2
$524K Sell
8,774
-384,766
-98% -$22.9M ﹤0.01% 914
2024
Q1
$11.3M Sell
393,540
-109,063
-22% -$5.19M 0.02% 592
2023
Q4
$21.1M Buy
502,603
+4,154
+0.8% +$141K 0.04% 410
2023
Q3
$16.4M Sell
498,449
-2,437
-0.5% -$83.1K 0.04% 462
2023
Q2
$17.7M Buy
500,886
+116,664
+30% +$3.86M 0.04% 458
2023
Q1
$10.9M Buy
384,222
+78,298
+26% +$2.76M 0.03% 607
2022
Q4
$12.7M Sell
305,924
-14,432
-5% -$620K 0.03% 516
2022
Q3
$13.3M Buy
320,356
+306,389
+2,194% +$12.2M 0.04% 466
2022
Q2
$456K Buy
+13,967
New +$508K ﹤0.01% 1797

Other funds holding PRCT

Mirae Asset Global Investments's PRCT Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Procept Biorobotics (PRCT) stake by 7.8% in Q2 2026, buying an estimated $14.9K and bringing the position to 8,217 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #1131.

Mirae Asset Global Investments first reported a position in PRCT in Q2 2022 and has held it in 17 quarters since. The position peaked at $21.1M in Q4 2023. 98 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Mirae Asset Global Investments held 8,217 shares of Procept Biorobotics worth $186K as of Q2 2026.
  • Mirae Asset Global Investments bought 596 Procept Biorobotics shares in Q2 2026, an estimated $14.9K.
  • Procept Biorobotics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1131 holding.
  • Mirae Asset Global Investments first reported a position in Procept Biorobotics in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Procept Biorobotics position peaked at $21.1M in Q4 2023.
  • 98 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.